GALIMBERTI STEFANIA

Risca, G., Pelucchi, S., Mariani, R., Botti, M., Capitoli, G., Di Gennaro, F., et al. (2026). Transferrin Saturation and Serum Ferritin Are Main Predictors of Liver Iron Content in Subjects With Hyperferritinemia. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 24(1 (January 2026)), 141-149 [10.1016/j.cgh.2025.02.033]. Dettaglio

Rossi, A., Romano, R., Fecarotta, S., Dell'Anno, M., Pecorella, V., Passeggio, R., et al. (2025). Multi-year enzyme expression in patients with mucopolysaccharidosis type VI after liver-directed gene therapy. MED, 6(4 (11 April 2025)) [10.1016/j.medj.2024.10.021]. Dettaglio

Petrosino, M., Gouvêa Bogossian, E., Rebora, P., Galimberti, S., Chesnut, R., Bouzat, P., et al. (2025). Neurological Pupil Index and Intracranial Hypertension in Patients with Acute Brain Injury: A Secondary Analysis of the ORANGE Study. JAMA NEUROLOGY, 82(2), 176-184 [10.1001/jamaneurol.2024.4189]. Dettaglio

Cazzaniga, M., Pepe, F., Rossi, E., Coltelli, L., Beano, A., Valerio, M., et al. (2025). A Phase 2, Open Label, Multicenter, Single Arm Trial Evaluating the Activity and Safety of Abemaciclib + Aromatase Inhibitors (AIs) as Second-Line Treatment After First-Line Fulvestrant in Hormone-Receptor-Positive (HR+), Human-Epidermal-Growth-Factor-Receptor-Negative (HER2-) Metastatic Breast Cancer (MBC) Patients. Final Results of HERMIONE-7 Trial. CLINICAL BREAST CANCER, 25(6), 560-565 [10.1016/j.clbc.2025.05.003]. Dettaglio

Cazzaniga, G., Capitoli, G., Barretta, R., Smith, A., Vischini, G., Papalia, G., et al. (2025). Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data. KIDNEY INTERNATIONAL REPORTS, 10(8), 2680-2689 [10.1016/j.ekir.2025.05.007]. Dettaglio